Home » Topics » BioWorld Science

BioWorld Science
RSS

LONP1 targeting sensitizes therapy-resistant tumor cells to sorafenib

July 13, 2022

Tenaya sets out rationale for targeting HDAC6 in heart failure

July 12, 2022

PARP/SIK2 inhibition shows potential for treating ovarian cancer and TNBC

July 12, 2022

iNtRON Biotechnology reports efficacy of CDL-200 against clinical isolates from CDI patients

July 12, 2022

MIF/CD74 axis identified as a critical determinant of TME composition in sarcoma

July 12, 2022

RS BioTherapeutics reports findings on RSBT-001 in mouse model of pulmonary inflammation

July 12, 2022

Novel murine models of diet-induced NASH developed

July 12, 2022

SBP-101 modulates polyamine metabolism and shows efficacy in ovarian cancer models

July 12, 2022

Chengdu Baiyu Pharmaceutical identifies new LANCL2 activators

July 12, 2022

Roche presents new Raf kinase B inhibitors

July 12, 2022

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...